Loading organizations...
Restore Medical Solutions is a technology company.
Restore Medical develops innovative medical devices focused on treating congestive heart failure. Its primary product, ContraBand, employs a transcatheter approach to restore hemodynamic balance within the heart. This minimally invasive therapeutic option is engineered to provide an alternative solution for patients who have not responded adequately to existing treatments, aiming to improve their overall clinical outcomes.
The company was co-founded by Ryan Ramkhelawan and Shawn Flynn. Originating in Atlanta, their foundational insight stemmed from identifying a critical need for more effective and less invasive medical interventions for complex cardiovascular conditions. This vision propelled the development of their specialized technology.
Restore Medical's offerings primarily serve patients diagnosed with congestive heart failure, particularly those with reduced ejection fraction (HFrEF) requiring advanced therapeutic modalities. The company’s long-term vision is dedicated to continually advancing novel medical device solutions that address significant unmet needs in cardiovascular medicine, thereby enhancing patient care and quality of life.
Restore Medical Solutions has raised $6.7M across 6 funding rounds.
Restore Medical Solutions has raised $6.7M in total across 6 funding rounds.
Restore Medical Solutions has raised $6.7M in total across 6 funding rounds.
Restore Medical Solutions's investors include Innova Memphis, Innova Capital, MB Venture Partners.
Restore Medical Solutions is a medical‑device technology company that builds sterilization tray systems and related workflows to reduce handling and improve efficiency in surgical instrument reprocessing for hospitals, surgery centers and sterile processing departments. [2][1]
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech / Health‑Care Landscape
Quick Take & Future Outlook
Notes and limits: The available public records reviewed (company site and industry databases) focus on the company’s sterile‑processing tray products and early commercial/regulatory milestones from the 2012–2014 timeframe and list customers and pilot outcomes; I did not find recent (post‑2014) detailed financials or product roadmap disclosures in the sources provided, so statements about current scale and near‑term plans are inferred from earlier traction and should be validated with up‑to‑date company filings or direct contact.[1][2][4]
Restore Medical Solutions has raised $6.7M across 6 funding rounds. Most recently, it raised $2.0M Series A in July 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2015 | $2.0M Series A | Innova Memphis | |
| Dec 1, 2014 | $380K Venture Round | Innova Memphis | |
| Jan 1, 2014 | $1.0M Series A | Innova Memphis | |
| Sep 1, 2013 | $250K Venture Round | Innova Memphis | |
| Dec 1, 2012 | $3.0M Series A | Innova Memphis, Innova Capital, MB Venture Partners | |
| May 1, 2012 | $50K Seed | Innova Memphis |